Cellular Logistics
Biotechnology, 504 S Rosa Rd Ste 200, Madison, Wisconsin, 53719, United States, 1-10 Employees
Who is CELLULAR LOGISTICS
Cellular Logistics, Inc. (CL) is a U.S. life sciences company that is dedicated to improving the lives of individuals who suffer from heart failure. CL was founded in 2016 by a multi-disc...
Read More
- Headquarters: 504 S Rosa Rd Ste 200, Madison, Wisconsin, 53719, United States
- Date Founded: 2016
- Employees: 1-10
- Revenue: Under $1 Million
- Active Tech Stack: See technologies
- CEO: Alex Vodenlich
Industry: Biotechnology
SIC Code: 2836
Does something look wrong? Fix it. | View contact records from CELLULAR LOGISTICS
Cellular Logistics Org Chart and Mapping
Similar Companies to Cellular Logistics
BellBrook Labs
- 11-50
- $ 10 Million to 25 Million
Intuitive Biosciences
- 11-50
- $ 5 Million to 10 Million
JangoBio
- 1-10
- $ 1 Million to 5 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Cellular Logistics
Answer: Cellular Logistics's headquarters are located at 504 S Rosa Rd Ste 200, Madison, Wisconsin, 53719, United States
Answer: Cellular Logistics's official website is https://cellogistics.com
Answer: Cellular Logistics's revenue is Under $1 Million
Answer: Cellular Logistics's SIC: 2836
Answer: Cellular Logistics has 1-10 employees
Answer: Cellular Logistics is in Biotechnology
Answer: Cellular Logistics top competitors include: BellBrook Labs , Intuitive Biosciences , JangoBio
Answer: Cellular Logistics contact info: Phone number: Website: https://cellogistics.com
Answer: Cellular Logistics, Inc. (CL) is a U.S. life sciences company that is dedicated to improving the lives of individuals who suffer from heart failure. CL was founded in 2016 by a multi-disciplinary team of physicians, scientists and business entrepreneurs at the University of Wisconsin-Madison. Our vision is to advance myocardial reparative and regenerative therapies that are poised to treat patients with heart failure. Our product promises to revitalize damaged heart tissue and improve outcomes for the estimated 30 million patients worldwide projected to suffer from heart failure by 2030.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month